The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
Exacerbations of COPD
Open accessAbstract
Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide. While COPD is a mainly chronic disease, a substantial number of patients suffer from exacerbations. Severe exacerbations are related to a significantly worse survival outcome. This review summarises the current knowledge on the different aspects of COPD exacerbations. The impact of risk factors and triggers such as smoking, severe airflow limitation, bronchiectasis, bacterial and viral infections and comorbidities is discussed. More severe exacerbations should be treated with β-agonists and anticholinergics as well as systemic corticosteroids. Antibiotic therapy should only be given to patients with presumed bacterial infection. Noninvasive ventilation is indicated in patients with respiratory failure. Smoking cessation is key to prevent further COPD exacerbations. Other aspects include choice of pharmacotherapy, including bronchodilators, inhaled corticosteroids, phosphodiesterase-4 inhibitors, long-term antibiotics and mucolytics. Better education and self-management as well as increased physical activity are important. Influenza and pneumococcal vaccination is recommended. Treatment of hypoxaemia and hypercapnia reduce the rate of COPD exacerbations, while most interventional bronchoscopic therapies increase exacerbation risk within the first months after the procedure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
Celli, B. R., MacNee, W., Agusti, A., Anzueto, A., Berg, B., Buist, A. S., Calverley, P. M. A., Chavannes, N., Dillard, T., Fahy, B., et al. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00014304 · Cited by 4,421
Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease
Hurst, J. R., Vestbo, J., Anzueto, A., Locantore, N., Müllerova, H., Tal-Singer, R., Miller, B., Lomas, D. A., Agusti, A., MacNee, W., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909883 · Cited by 2,981
Global Burden of Disease and Risk Factors
(2006) · World Bank, Washington, DC eBooks · doi:10.1596/978-0-8213-6262-4 · Cited by 2,605
NOCTURNAL OXYGEN THERAPY TRIAL GROUP* (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-3-391 · Cited by 2,218
Global burden of COPD: risk factors, prevalence, and future trends
Mannino, D. M., & Buist, A. S. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61380-4 · Cited by 2,079
Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease
Soler-Cataluna, J. J. (2005) · Thorax · doi:10.1136/thx.2005.040527 · Cited by 1,931
Anthonisen, N. R. (1994) · JAMA · doi:10.1001/jama.1994.03520190043033 · Cited by 1,341
Intermittent Administration of Inhaled Tobramycin in Patients with Cystic Fibrosis
Ramsey, B. W., Pepe, M. S., Quan, J. M., Otto, K. L., Montgomery, A. B., Williams-Warren, J., Vasiljev-K, M., Borowitz, D., Bowman, C. M., Marshall, B. C., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901073400104 · Cited by 1,300
Comorbidities and Risk of Mortality in Patients with Chronic Obstructive Pulmonary Disease
Divo, M., Cote, C., de Torres, J. P., Casanova, C., Marin, J. M., Pinto-Plata, V., Zulueta, J., Cabrera, C., Zagaceta, J., Hunninghake, G., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201201-0034oc · Cited by 1,275
Global and regional estimates of COPD prevalence: Systematic review and meta–analysis
Adeloye, D., Chua, S., Lee, C., Basquill, C., Papana, A., Theodoratou, E., Nair, H., Gasevic, D., Sridhar, D., Campbell, H., et al. (2015) · Journal of Global Health · doi:10.7189/jogh.05.020415 · Cited by 1,264
Azithromycin for prevention of exacerbations of COPD
Albert, R. K., Connett, J., Bailey, W. C., Casaburi, R., Cooper, J. A. D., Criner, G. J., Curtis, J. L., Dransfield, M. T., Han, M. K., Lazarus, S. C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1104623 · Cited by 1,226
Calverley, P., Pauwels, R., Vestbo, J., Jones, P., Pride, N., Gulsvik, A., Anderson, J., & Maden, C. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12459-2 · Cited by 1,221
New Strains of Bacteria and Exacerbations of Chronic Obstructive Pulmonary Disease
Sethi, S., Evans, N., Grant, B. J. B., & Murphy, T. F. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012561 · Cited by 1,047
Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease
Puhan, M. A., Gimeno-Santos, E., Cates, C. J., & Troosters, T. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005305.pub4 · Cited by 991
Physical Activity Is the Strongest Predictor of All-Cause Mortality in Patients With COPD
Waschki, B., Kirsten, A., Holz, O., Müller, K.-C., Meyer, T., Watz, H., & Magnussen, H. (2011) · Chest · doi:10.1378/chest.10-2521 · Cited by 951
(1981) · The Lancet · doi:10.1016/s0140-6736(81)91970-x · Cited by 884
Vogelmeier, C. F., Criner, G. J., Martinez, F. J., Anzueto, A., Barnes, P. J., Bourbeau, J., Celli, B. R., Chen, R., Decramer, M., Fabbri, L. M., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.00214-2017 · Cited by 881
Self-citationEffect of Systemic Glucocorticoids on Exacerbations of Chronic Obstructive Pulmonary Disease
Niewoehner, D. E., Erbland, M. L., Deupree, R. H., Collins, D., Gross, N. J., Light, R. W., Anderson, P., & Morgan, N. A. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906243402502 · Cited by 875
Stuart, H., Bishop, J. F., Clark, T. J. H., Ac, D., Je, C., & Flenley, D. C. (1981) · PubMed · Cited by 845
Lightowler, J. V., Wedzicha, J. A., Elliott, M. W., & Ram, F. S. F. (2003) · BMJ · doi:10.1136/bmj.326.7382.185 · Cited by 843
A Randomized Study of Endobronchial Valves for Advanced Emphysema
Sciurba, F. C., Ernst, A., Herth, F. J. F., Strange, C., Criner, G. J., Marquette, C. H., Kovitz, K. L., Chiacchierini, R. P., Goldin, J., & McLennan, G. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0900928 · Cited by 832
Vanfleteren, L. E. G. W., Spruit, M. A., Groenen, M., Gaffron, S., van Empel, V. P. M., Bruijnzeel, P. L. B., Rutten, E. P. A., Op ’t Roodt, J., Wouters, E. F. M., & Franssen, F. M. E. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201209-1665oc · Cited by 828
Köhnlein, T., Windisch, W., Köhler, D., Drabik, A., Geiseler, J., Hartl, S., Karg, O., Laier-Groeneveld, G., Nava, S., Schönhofer, B., et al. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70153-5 · Cited by 815
Suissa, S., Dell'Aniello, S., & Ernst, P. (2012) · Thorax · doi:10.1136/thoraxjnl-2011-201518 · Cited by 779
Pascoe, S., Locantore, N., Dransfield, M. T., Barnes, N. C., & Pavord, I. D. (2015) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00106-x · Cited by 743
SCANLON, P. D., CONNETT, J. E., WALLER, L. A., ALTOSE, M. D., BAILEY, W. C., SONIA BUIST, A., & e Lung Health Study Research Group, D. P. T. F. T. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.2.9901044 · Cited by 731
Tiotropium versus Salmeterol for the Prevention of Exacerbations of COPD
Vogelmeier, C., Hederer, B., Glaab, T., Schmidt, H., Rutten-van Mölken, M. P. M. H., Beeh, K. M., Rabe, K. F., & Fabbri, L. M. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1008378 · Cited by 684
Self-citationManagement of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline
Wedzicha, J. A., Miravitlles, M., Hurst, J. R., Calverley, P. M. A., Albert, R. K., Anzueto, A., Criner, G. J., Papi, A., Rabe, K. F., Rigau, D., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.00791-2016 · Cited by 683
Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease
Pavord, I. D., Chanez, P., Criner, G. J., Kerstjens, H. A. M., Korn, S., Lugogo, N., Martinot, J.-B., Sagara, H., Albers, F. C., Bradford, E. S., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1708208 · Cited by 625
Bafadhel, M., McKenna, S., Terry, S., Mistry, V., Pancholi, M., Venge, P., Lomas, D. A., Barer, M. R., Johnston, S. L., Pavord, I. D., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201108-1553oc · Cited by 612
Withdrawal of Inhaled Glucocorticoids and Exacerbations of COPD
Magnussen, H., Disse, B., Rodriguez-Roisin, R., Kirsten, A., Watz, H., Tetzlaff, K., Towse, L., Finnigan, H., Dahl, R., Decramer, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1407154 · Cited by 606
Self management for patients with chronic obstructive pulmonary disease
Zwerink, M., Brusse-Keizer, M., van der Valk, P. D., Zielhuis, G. A., Monninkhof, E. M., van der Palen, J., Frith, P. A., & Effing, T. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002990.pub3 · Cited by 572
Rohde, G. (2003) · Thorax · doi:10.1136/thorax.58.1.37 · Cited by 524
Antibiotic Treatment of Exacerbations of COPD
Stolz, D., Christ-Crain, M., Bingisser, R., Leuppi, J., Miedinger, D., Müller, C., Huber, P., Müller, B., & Tamm, M. (2007) · Chest · doi:10.1378/chest.06-1500 · Cited by 521
A Randomized Trial of Long-Term Oxygen for COPD with Moderate Desaturation
The Long-Term Oxygen Treatment Trial Research Group (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1604344 · Cited by 428
Singh, D., Papi, A., Corradi, M., Pavlišová, I., Montagna, I., Francisco, C., Cohuet, G., Vezzoli, S., Scuri, M., & Vestbo, J. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31354-x · Cited by 425
Vestbo, J., Papi, A., Corradi, M., Blazhko, V., Montagna, I., Francisco, C., Cohuet, G., Vezzoli, S., Scuri, M., & Singh, D. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30188-5 · Cited by 425
Leuppi, J. D., Schuetz, P., Bingisser, R., Bodmer, M., Briel, M., Drescher, T., Duerring, U., Henzen, C., Leibbrandt, Y., Maier, S., et al. (2013) · JAMA · doi:10.1001/jama.2013.5023 · Cited by 424
Role of Infection in Chronic Bronchitis
Tager, I., & Speizer, F. E. (1975) · New England Journal of Medicine · doi:10.1056/nejm197503132921105 · Cited by 421
Influenza vaccine for patients with chronic obstructive pulmonary disease
Poole, P., Chacko, E. E., Wood-Baker, R., & Cates, C. J. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002733.pub2 · Cited by 371
Nutritional assessment and therapy in COPD: a European Respiratory Society statement
Schols, A. M., Ferreira, I. M., Franssen, F. M., Gosker, H. R., Janssens, W., Muscaritoli, M., Pison, C., Rutten-van Mölken, M., Slinde, F., Steiner, M. C., et al. (2014) · European Respiratory Journal · doi:10.1183/09031936.00070914 · Cited by 360
Gender differences in COPD: are women more susceptible to smoking effects than men?
Sorheim, I.-C., Johannessen, A., Gulsvik, A., Bakke, P. S., Silverman, E. K., & DeMeo, D. L. (2010) · Thorax · doi:10.1136/thx.2009.122002 · Cited by 338
Nutritional supplementation for stable chronic obstructive pulmonary disease
Ferreira, I. M., Brooks, D., White, J., & Goldstein, R. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000998.pub3 · Cited by 326
Garcia-Aymerich, J., Gomez, F. P., Benet, M., Farrero, E., Basagana, X., Gayete, A., Pare, C., Freixa, X., Ferrer, J., Ferrer, A., et al. (2011) · Thorax · doi:10.1136/thx.2010.154484 · Cited by 319
Inhaled Corticosteroids and the Risks of Diabetes Onset and Progression
Suissa, S., Kezouh, A., & Ernst, P. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2010.06.019 · Cited by 317
Pulmonary toxicity of e-cigarettes
Chun, L. F., Moazed, F., Calfee, C. S., Matthay, M. A., & Gotts, J. E. (2017) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00071.2017 · Cited by 311
Major air pollutants and risk of COPD exacerbations: a systematic review and meta-analysis
Li, J., Sun, S., Tang, R., Qiu, H., Huang, Q., Mason, T., & Tian, L. (2016) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s122282 · Cited by 283
Decramer, M. L., Chapman, K. R., Dahl, R., Frith, P., Devouassoux, G., Fritscher, C., Cameron, R., Shoaib, M., Lawrence, D., Young, D., et al. (2013) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70158-9 · Cited by 277
Loke, Y. K., Cavallazzi, R., & Singh, S. (2011) · Thorax · doi:10.1136/thx.2011.160028 · Cited by 267
Sciurba, F. C., Criner, G. J., Strange, C., Shah, P. L., Michaud, G., Connolly, T. A., Deslée, G., Tillis, W. P., Delage, A., Marquette, C.-H., et al. (2016) · JAMA · doi:10.1001/jama.2016.6261 · Cited by 242
Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH study
Jenkins, C. R., Celli, B., Anderson, J. A., Ferguson, G. T., Jones, P. W., Vestbo, J., Yates, J. C., & Calverley, P. M. A. (2012) · European Respiratory Journal · doi:10.1183/09031936.00194610 · Cited by 235
Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease
Chong, J., Leung, B., & Poole, P. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002309.pub5 · Cited by 218
The role of viral infections in exacerbations of chronic obstructive pulmonary disease and asthma
Hewitt, R., Farne, H., Ritchie, A., Luke, E., Johnston, S. L., & Mallia, P. (2016) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753465815618113 · Cited by 186
Electronic Cigarettes. A Position Statement of the Forum of International Respiratory Societies
Schraufnagel, D. E., Blasi, F., Drummond, M. B., Lam, D. C. L., Latif, E., Rosen, M. J., Sansores, R., & Van Zyl-Smit, R. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201407-1198pp · Cited by 182
Herth, F. J. F., Valipour, A., Shah, P. L., Eberhardt, R., Grah, C., Egan, J., Ficker, J. H., Wagner, M., Witt, C., Liebers, U., et al. (2016) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(16)00045-x · Cited by 177
Rennard, S. I., Locantore, N., Delafont, B., Tal‐Singer, R., Silverman, E. K., Vestbo, J., Miller, B. E., Bakke, P. S., Celli, B. R., Calverley, P. M. A., et al. (2015) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201403-125oc · Cited by 169
Prevention of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline
Wedzicha, J. A., Calverley, P. M. A., Albert, R. K., Anzueto, A., Criner, G. J., Hurst, J. R., Miravitlles, M., Papi, A. A., Rabe, K. F., Comas, D. R., et al. (2017) · doi:10.7892/boris.105695 · Cited by 168
Role of infection in chronic bronchitis.
Gump, D. W., Phillips, C. A., Forsyth, B. R., McIntosh, K., Lamborn, K. R., & Stouch, W. H. (1976) · PubMed · doi:10.1164/arrd.1976.113.4.465 · Cited by 167
Prevention of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline
Wedzicha, J. A., Calverley, P. M. A., Albert, R. K., Anzueto, A., Criner, G. J., Hurst, J. R., Miravitlles, M., Papi, A., Rabe, K. F., Rigau, D., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.02265-2016 · Cited by 164
Sannigrahi, S., Wang, C., Zhou, X., Zhang, N., Humphries, M., Wang, L., Thach, C., Patalano, F., Banerji, D., & Zhong, N. S. (2015) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s84436 · Cited by 160
Ni, Y., Shi, G., Yu, Y., Hao, J., Chen, T., & Song, H. (2015) · International Journal of COPD · doi:10.2147/copd.s83910 · Cited by 158
Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD)
Herath, S., & Poole, P. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009764.pub2 · Cited by 150
Miller, B. E., Tal‐Singer, R., Rennard, S. I., Furtwaengler, A., Leidy, N. K., Lowings, M., Martin, U. J., Martin, T. R., Merrill, D. D., Snyder, J., et al. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201509-1722pp · Cited by 148
Biomarkers Predictive of Exacerbations in the SPIROMICS and COPDGene Cohorts
Keene, J., Jacobson, S. R., Kechris, K. J., Kinney, G. L., Foreman, M. G., Doerschuk, C. M., Make, B. J., Curtis, J. L., Rennard, S. I., Barr, R. G., et al. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201607-1330oc · Cited by 147
Evidence for harm reduction in COPD smokers who switch to electronic cigarettes
Polosa, R., Morjaria, J. B., Caponnetto, P., Prosperini, U., Russo, C., Pennisi, A., & Bruno, C. M. (2016) · Respiratory Research · doi:10.1186/s12931-016-0481-x · Cited by 147
Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease
Poole, P., Chong, J., & Cates, C. J. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001287.pub5 · Cited by 141
Nicht-invasive Beatmung als Therapie der akuten respiratorischen Insuffizienz
Westhoff, M., Schönhofer, B., Neumann, P., Bickenbach, J., Barchfeld, T., Becker, H. F., Dubb, R., Fuchs, H. W., Heppner, H. J., Janssens, U., et al. (2015) · Pneumologie · doi:10.1055/s-0034-1393309 · Cited by 138
Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease
Walters, J. A., Tang, J., Poole, P., & Wood-Baker, R. R. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001390.pub4 · Cited by 131
New Therapies for Asthma and Chronic Obstructive Pulmonary Disease
Gross, N. J., & Barnes, P. J. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201610-2074pp · Cited by 111
Guerrero, M., Crisafulli, E., Liapikou, A., Huerta, A. H., Gabarrús, A., Chetta, A. A., Soler, N., & Torres, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150737 · Cited by 101
Antibiotics for treatment and prevention of exacerbations of chronic obstructive pulmonary disease
Wilson, R., Sethi, S., Anzueto, A., & Miravitlles, M. (2013) · Journal of Infection · doi:10.1016/j.jinf.2013.08.010 · Cited by 87
Kiser, T. H., Allen, R. R., Valuck, R. J., Moss, M., & Vandivier, R. W. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201401-0058oc · Cited by 86
Characterisation of exacerbation risk and exacerbator phenotypes in the POET-COPD trial
Beeh, K. M., Glaab, T., Stowasser, S., Schmidt, H., Fabbri, L. M., Rabe, K. F., & Vogelmeier, C. F. (2013) · Respiratory Research · doi:10.1186/1465-9921-14-116 · Cited by 81
Self-citationLow level air pollution and exacerbation of existing copd: a case crossover analysis
DeVries, R., Kriebel, D., & Sama, S. R. (2016) · Environmental Health · doi:10.1186/s12940-016-0179-z · Cited by 76
Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease
Chong, J., Leung, B., & Poole, P. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002309.pub4 · Cited by 55
Pharmacological strategies to reduce exacerbation risk in COPD: a narrative review
Miravitlles, M., D’Urzo, A. D., Singh, D., & Koblížek, V. (2016) · Respiratory Research · doi:10.1186/s12931-016-0425-5 · Cited by 54
DiSantostefano, R. L., Sampson, T., Le, H. V., Hinds, D. R., Davis, K. J., & Bakerly, N. D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097149 · Cited by 53
Laue, J., Reierth, E., & Melbye, H. (2015) · npj Primary Care Respiratory Medicine · doi:10.1038/npjpcrm.2015.2 · Cited by 37
Sundh, J., Johansson, G. S., Larsson, K., Lindén, A., Löfdahl, C., Sandström, T., & Janson, C. (2015) · International Journal of COPD · doi:10.2147/copd.s91362 · Cited by 29
Esteban, C., García‐Gutiérrez, S., Legarreta, M. J., Antón-Ladislao, A., González, N., Lafuente, I., de Larrea, N. F., Vidal, S., Baré, M., Quintana, J. M., et al. (2016) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412555.2016.1188903 · Cited by 23
Wedzicha, J. A., Buhl, R., Lawrence, D., & Young, D. (2014) · Respiratory Medicine · doi:10.1016/j.rmed.2014.10.011 · Cited by 14
Cited by
Predictors of adverse prognosis in COVID‐19: A systematic review and meta‐analysis
Figliozzi, S., Masci, P. G., Ahmadi, N., Tondi, L., Koutli, E., Aimo, A., Stamatelopoulos, K., Dimopoulos, M., Caforio, A. L. P., & Georgiopoulos, G. (2020) · European Journal of Clinical Investigation · doi:10.1111/eci.13362 · Cited by 361
Use of precision cut lung slices as a translational model for the study of lung biology
Liu, G., Betts, C., Cunoosamy, D. M., Åberg, P. M., Hornberg, J. J., Sivars, K. B., & Cohen, T. S. (2019) · Respiratory Research · doi:10.1186/s12931-019-1131-x · Cited by 206
Ritz, T., Salsman, M. L., Young, D. A., Lippert, A. R., Khan, D. A., & Ginty, A. T. (2021) · Brain, Behavior, & Immunity - Health · doi:10.1016/j.bbih.2021.100255 · Cited by 17
Metadata
- Authors
- Viniol, C., & Vogelmeier, C. F.
- Venue
- European Respiratory Review
- Publisher
- European Respiratory Society (ERS)
- Published
- 2018-03-14
- Volume
- 27
- Issue
- 147
- Pages
- 170103
- ISSN
- 0905-9180 (ISSN-L)
- 1600-0617
- OpenAlex
- W2794019240
- Cited by
- 283
- References
- 82
- FWCI
- 20.46
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.